Analysis of Tianeptine in Dietary Supplements

Author:

Seale Jared T.1,Garden Emily A.2,French John M. T.3,McDougal Owen M.1ORCID

Affiliation:

1. Department of Chemistry & Biochemistry, Boise State University, Boise, ID 83725, USA

2. Department of Chemistry, Montana Technological University, Butte, MT 59701, USA

3. School of Medicine, University of Missouri, Columbia, MO 65212, USA

Abstract

In the United States (US), tianeptine is sold as a dietary supplement under the trade name Tianaa™. Tianeptine is a synthetic drug prescribed by physicians as an antidepressant in parts of Europe, Asia and South America. The drug is not permitted for use by physicians in the US, because it is a μ-opioid receptor agonist with a propensity for severe addiction. As the incidence of Tianaa™-related opioid addiction across the southern US escalates, the current study aimed to quantify tianeptine in over-the-counter Tianaa™ White, Red, and Green products. The results of this investigation measured tianeptine levels between 3.1 and 10.9 mg per 531 mg capsules. Tianaa™ White capsules consistently contained the least tianeptine, while Green had the most. The close inspection of Tianaa™ products showed that capsule mass varied by as much as 16% from label claim, and the amount of tianeptine per capsule varied by as much as 35% from the average measured amount for each product. Tianaa™ Red contains kava leaf extract, which led to the identification of four kavapyrone components by mass spectrometry. The data presented provide insight into tianeptine quantity and capsule mass variation for Tianaa™ supplements sold to customers naive to the risk of addiction.

Funder

Institutional Development Awards

The Biomolecular Research Center at Boise State University (BSU) Biomolecular Research Center

National Science Foundation

M. J. Murdock Charitable Trust

Lori and Duane Stueckle

Idaho State Board of Education

Publisher

MDPI AG

Reference25 articles.

1. Medicines and Healthcare products Regulatory Agency (MHRA) (2022). The British Pharmacopeia, 2022. Monographs: Tianeptine Sodium.

2. Malen, C., Danree, B., en Laye, S.G., and Poignant, J.-C. (1973). Tricyclic Compounds. (#3758528), U.S. Patent, Available online: https://patentimages.storage.googleapis.com/94/81/93/24ca0b63a45d8a/US3758528.pdf.

3. Rangisetty, J.B., Pallagurla, M.R., and Bhudeti, R. (2010). Novel Process for the Preparation of 7-((3-Chloro-6-methyI-5,5-dioxo-6,11-dihydro dibenzo(c,f) (1,2) thiazepin-11-yl)amino) heptanoate. (WO 2010/070667A2), International Patent.

4. Cell atrophy and loss in depression: Reversal by antidepressant treatment;Banasr;Curr. Opin. Cell Biol.,2011

5. Tianeptine: A review of its use in depressive disorders;Wagstaff;CNS Drugs,2001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3